High prevalence of Transmitted HIV Drug Resistance Mutations in a cohort of newly diagnosed HIV- infected patients at entrance to care in the period from 2014 to 2015: the Croatian data (CROSBI ID 683554)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Oroz, Maja ; Planinic, Ana ; Židovec Lepej, Snježana ; Begovac, Josip
engleski
High prevalence of Transmitted HIV Drug Resistance Mutations in a cohort of newly diagnosed HIV- infected patients at entrance to care in the period from 2014 to 2015: the Croatian data
Croatia has a centralized system of HIV clinical care and all patients are treated at University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Zagreb (UHID). Previous national study by Grgic et al. showed a high prevalence of transmitted drug resistance (TDR) of 21.6% (in the period 2006 to 2008), mainly attributed to the transmission clusters among MSM characterized by the presence of T215S mutation (1). In order to continue national TDR surveillance, we analyzed the prevalence of TDR mutations for the time period 2014-2015. Included were newly diagnosed, treatment-naive patients who entered clinical care at UHID during the study period.
HIV-1 ; primary drug resistance
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
72-72.
2018.
objavljeno
Podaci o matičnoj publikaciji
Abstract book of the 16th EU Meeting on HIV&Hepatitis ; Reviews in Antiviral Therapy & Infectious Diseases, 2018
Podaci o skupu
16th European Meeting on HIV & Hepatitis "Treatment Strategies & Antiviral Drug Resistance"
poster
30.05.2018-01.06.2018
Rim, Italija